Zentalis Pharmaceuticals Overview
Zentalis Pharmaceuticals Target Price
Analysts' 12-month price predictions for ZNTL.
Get informed when a big investor buys or sells
+ FollowShare Price
$3.87
Average Target Price
$10.00
158.4% upside
158.4% upside2 analysts in the last 4 months
High: $10 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-22 | H.C. WainwrightAndrew Fein | $10 | 158.4% upside |  |
| 2026-04-10 | Guggenheim | $10 | 158.4% upside | |
| 2025-11-11 | Leerink PartnersAndrew Berens | $2 |  48.3% downside | |
| 2024-06-18 | JefferiesAkash Tewari | $6 | 55% upside | |
| 2024-06-18 | Morgan StanleyMatthew Harrison | $8 | 106.7% upside | |
| 2024-06-18 | Stifel NicolausBradley Canino | $10 | 158.4% upside | |
| 2024-06-18 | WedbushRobert Driscoll | $4 | 3.4% upside | |
| 2024-05-07 | Stifel NicolausBradley Canino | $32 | 726.9% upside | |
| 2022-11-14 | Wedbush | $32 | 726.9% upside | |
| 2022-11-11 | Morgan Stanley | $55 | 1321.2% upside | |
| 2022-11-11 | Guggenheim | $28 | 623.5% upside | |
| 2022-08-10 | Leerink Partners | $42 | 985.3% upside | |
| 2022-08-10 | H.C. Wainwright | $55 | 1321.2% upside | |
| 2022-07-29 | Stifel NicolausBradley Canino | $70 | 1708.8% upside | |